Atlas Trials

Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders

Clinical trial NCT05962216 · RECRUITING

Trial details

NCT number
NCT05962216
Sponsor
Dr. Albert Kar-Kin Chung
Status
RECRUITING
Study type
OBSERVATIONAL
PsychosisDepression
Start date
2023-07-01
Primary completion
2026-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.